VYNE Therapeutics Inc. (VYNE)

VYNE Therapeutics Revenue

VYNE Therapeutics had revenue of $121.00K in the quarter ending September 30, 2024, with 6.14% growth. This brings the company's revenue in the last twelve months to $493.00K, up 39.27% year-over-year. In the year 2023, VYNE Therapeutics had annual revenue of $424.00K, down -11.11%.

• Revenue (ttm): $493.00K
• Revenue Growth: +39.27%
• P/S Ratio: 232.30
• Revenue / Employee: $49,300
• Employees: 10
• Market Cap: 42.48M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	424.00K	-53.00K	-11.11%
Dec 31, 2022	477.00K	-454.00K	-48.76%
Dec 31, 2021	931.00K	-20.06M	-95.57%
Dec 31, 2020	20.99M	20.55M	4,638.83%
Dec 31, 2019	443.00K	-3.15M	-87.68%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.